Abstract Background Serious infection complicates a small proportion of prosthetic vascular grafts and usually follows implantation of bacteria at the time of graft insertion. The aim of this study was to determine whether the use of a rifampicin-bonded, gelatin-coated Dacron graft (Gelsoft/Gelseal; Sulzer Vascutek) could reduce the rate of infective complications after extra-anatomic bypass. Methods In a multicentre study involving 14 vascular units, 257 patients underwent extra-anatomic bypass. There were 178 men and 79 women, of median age 69 (range 43–92) years. Some 132 (51 per cent) had no risk factors for wound or graft sepsis, 82 (32 per cent) had one and 43 (17 per cent) had two or more risk factors. Patients were randomized to rifampicin bonding (rifampicin 1 mg ml−1 soak for 15 min before insertion) (n = 123) or control (n = 134). The authors have previously reported small, but not statistically significant, reductions in total perioperative wound complications, antibiotic requirements and delayed hospital discharge in favour of patients with bonded grafts. Results Of 257 patients originally randomized, follow-up to 2 years or death is available for 197 patients; 60 have died. A total of ten patients have had serious wound or graft infections (Szilagyi grade III), four with unbonded and six with bonded grafts (P not significant). All occurred within 6 months of operation. The graft fabric was involved in eight patients. Treatment and outcome are listed in the Table below. Conclusion It has not been possible to show any advantage for the routine use of antibiotic bonding for extra-anatomic reconstruction.
Read full abstract